RVQ-63392-87526
3 vaccinations
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 121 / NY
- Registered
- 2021-10-19
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-16
Dose 1 — Pfizer-BioNTech
-
2021-06-06
Dose 2 — Pfizer-BioNTech
-
2021-10-19
Registered in v-safe
- 2021-12-05
-
2022-04-01
Dose 3 — Moderna
- 2022-05-03
- 2022-05-06
- 2022-05-13
- 2022-07-01
-
2022-10-03
Survey response — 6 months, dose 3MedDRA: Bell's palsy — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Bell's palsyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-10-06
-
2022-10-06
Callback requested for03:30PM ET
- 2022-10-07
-
2022-10-07
Call successfulCompleted over the phone
- 2023-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-16 | Pfizer-BioNTech | No |
| 2 | 2021-06-06 | Pfizer-BioNTech | No |
| 3 | 2022-04-01 | Moderna | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 12 — 6 months, dose 3
Symptoms: Bell's palsy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bell's palsy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release